Zobrazeno 1 - 10
of 16
pro vyhledávání: '"K A Sychevskaya"'
Autor:
K. A. Sychevskaya, S. K. Kravchenko
Publikováno v:
Онкогематология, Vol 17, Iss 2, Pp 95-106 (2022)
Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contraThe review presents the results of a combined analysis of literature data and own clinical observations regarding the safety and feasibility of using mon
Externí odkaz:
https://doaj.org/article/32ea6bad82d441068fa4496726865c2c
Autor:
K. A. Sychevskaya, A. E. Misyurina, E. E. Nikulina, N. V. Risinskaya, R. R. Abdurashidova, Z. T. Sarakaeva, A. U. Magomedova, A. B. Sudarikov, S. K. Kravchenko
Publikováno v:
Онкогематология, Vol 17, Iss 2, Pp 60-74 (2022)
Background. The study of genetic predictors of non-Hodgkin’s lymphomas prognosis is one of the most relevant areas of oncohematology. It is extremely interesting to search for integral markers that reflect the most important stages of tumor pathoge
Externí odkaz:
https://doaj.org/article/fb5f76ac8e184413afefab39fff9935a
Autor:
M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 16, Iss 3, Pp 86-94 (2021)
Background. Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive tumors of the lymphatic system. Despite the frequency of occurrence, there is no single algorithm for treating DLBCL patients with poor prognostic factors. R-C
Externí odkaz:
https://doaj.org/article/bc80e43b32a248c29b17d3ba1e25972b
Autor:
K. A. Sychevskaya, S. K. Kravchenko, N. V. Risinskaya, А. Е. Misyurina, E. E. Nikulina, F. E. Babaeva, A. B. Sudarikov
Publikováno v:
Онкогематология, Vol 16, Iss 2, Pp 56-69 (2021)
Background. Genetic instability, an important phenomenon involved in oncogenic transformation and tumor progression, is associated with the insufficiency of the multicomponent DNA repair complex, in particular, the nucleotide mismatch repair (MMR) sy
Externí odkaz:
https://doaj.org/article/ee766794e6c44ae1977c8e12939c774e
Autor:
A. N. Narovlyansky, V. V. Poloskov, A. M. Ivanova, S. K. Kravchenko, F. E. Babayeva, K. A. Sychevskaya, M. V. Mezentseva, I. A. Suetina, L. I. Russu, A. V. Izmest’eva, T. P. Ospelnikova, A. A. Sarymsakov, F. I. Ershov
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 5, Pp 284-293 (2020)
Introduction. Medicines from the group of interferon inducers (IFNs) “swith on” the synthesis of type 1 interferons (IFN-I) and induce the expression of IFN-stimulated genes (ISGs) that regulate innate immunity reactions and protect the host from
Externí odkaz:
https://doaj.org/article/91fd4eeb0cb24500820c03af366ce693
Autor:
M. V. Erokhina, L. N. Lepekha, A. E. Ergeshov, E. Yu. Rybalkina, S. S. Sadovnikova, K. A. Sychevskaya
Publikováno v:
Туберкулез и болезни лёгких, Vol 94, Iss 9, Pp 53-58 (2016)
Cells of the host containing special proteins-transporters, so-called proteins of multiple drug resistance (MDR proteins) can contribute to the drug resistance formation.Goal of the study: to define specific expression of gene and distribution of mai
Externí odkaz:
https://doaj.org/article/bc6401878a0646bd9ffc403d270e9270
Autor:
I. A. Suetina, A M Ivanova, F E Babayeva, A. N. Narovlyansky, L. I. Russu, T P Ospelnikova, A A Sarymsakov, K A Sychevskaya, S K Kravchenko, A V Izmest'eva, Ershov Fi, V V Poloskov, M. V. Mezentseva
Publikováno v:
Voprosy virusologii. 65(5)
Introduction . Medicines from the group of interferon inducers (IFNs) “swith on” the synthesis of type 1 interferons (IFN-I) and induce the expression of IFN-stimulated genes (ISGs) that regulate innate immunity reactions and protect the host fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b8fc487e87b6cb122babc8bfe37410
https://pubmed.ncbi.nlm.nih.gov/33533212
https://pubmed.ncbi.nlm.nih.gov/33533212
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S405
Context CD23 expression in follicular lymphoma (FL) is associated with better overall survival (OS). It is known that FL cases with inguinal lymph node lesions and large-cell morphology are characterized by CD23 expression, which is a distinctive fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e096ac9525e24ef99d8ff3044ce68a3
https://doi.org/10.1016/s2152-2650(21)01914-5
https://doi.org/10.1016/s2152-2650(21)01914-5
Autor:
Nikolay M. Kapranov, Irina V. Galtseva, K A Sychevskaya, Fatima Babaeva, Sergey K. Kravchenko, Ksenia Nikiforova, Anna Misyurina, Hunan Julhakyan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S386
Context Anti-tumor effects in patients with non-Hodgkin lymphomas (NHL) receiving chemotherapy are achieved as a result of the synergy between cytotoxic effects of chemotherapy and anti-tumor autoimmunity. However, chemotherapeutic depletion of lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc108ce5f47bbc316302773a26e1f26e
https://doi.org/10.1016/s2152-2650(21)01878-4
https://doi.org/10.1016/s2152-2650(21)01878-4
Autor:
Svetlana Ju. Smirnova, Vadim R. Gorodetskiy, Nataliya G. Chernova, Nataliya V. Ryzhikova, Hunan Julhakyan, Elena V. Naumova, Yulia V. Sidorova, Andrey Sudarikov, K A Sychevskaya
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(4)
Polymerase chain reaction (PCR) analysis of rearranged T-cell receptor (TCR) genes is a valuable diagnostic tool for differential diagnosis of T-cell large granular lymphocytic (T-LGL) leukemia and reactive lymphocytosis. Age-related narrowing of T-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db4d061e02586cf46b937b0656075b08
https://pubmed.ncbi.nlm.nih.gov/32046930
https://pubmed.ncbi.nlm.nih.gov/32046930